Graphite Bio, Inc.

NASDAQ:GRPH

3.18 (USD) • At close March 21, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -49.769-124.651-101.052-70.76-68.373-0.109
Depreciation & Amortization 0.0582.4072.3520.7340.1210
Deferred Income Tax 02.3580000
Stock Based Compensation 6.36510.57413.5347.8710.1770
Change In Working Capital 0-39.223-7.208-2.4981.7090.01
Accounts Receivables 00-0.014-0.01400
Inventory 0000.01400
Accounts Payables -4.279-2.3580.1941.8250.594-0.012
Other Working Capital 0-36.865-7.388-4.3231.1150.022
Other Non Cash Items 058.5284.39411.80157.6450.08
Operating Cash Flow -59.391-90.007-87.98-52.852-8.721-0.019
Investing Activities:
Investments In Property Plant And Equipment -0.468-10.856-6.594-5.74-1.5450
Acquisitions Net 000.235000
Purchases Of Investments -241.911-28.129-405.519000
Sales Maturities Of Investments 87.9263.427170.25000
Other Investing Activites 00-0.235000
Investing Cash Flow -154.479226.346-241.863-5.74-1.5450
Financing Activities:
Debt Repayment 000000
Common Stock Issued 79.5130.2570.676251.32330.0770
Common Stock Repurchased 0-0.067-0.079000
Dividends Paid 000000
Other Financing Activities 119.4890.190.597417.46730.0770
Financing Cash Flow 199.0020.190.597417.46730.0770
Other Information:
Effect Of Forex Changes On Cash 01.6020000
Net Change In Cash -14.868138.131-329.246358.87519.811-0.019
Cash At End Of Period 20.272185.86149.446378.69219.8170.006